Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Allogene Therapeutics Q4 EPS $(0.54) Beats $(0.60) Estimate

Allogene Therapeutics (NASDAQ:ALLO) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.60) by 10 percent. This is a 1.89 percent decrease over losses of $(0.53) per share from
byBill Haddad
February 23, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Allogene Therapeutics (NASDAQ:ALLO) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.60) by 10 percent. This is a 1.89 percent decrease over losses of $(0.53) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Woodward’s Earnings: A Preview

By Benzinga Insights
Today, 2:10 PM
Woodward (NASDAQ:WWD) is set to give its latest quarterly earnings report on Monday, 2022-01-31. Here's what investors need to know before the announcement. Analysts estimate that Woodward will likely report an Earnings Per Share (EPS) of $0.81.

WWD